Canada is a world leader in the study of RNA research, with more than $500M in tri-council funding to academic RNA investigators in the last 10 years, multiple RNA research international prize winners (including Nobel prize winners) and essential discoveries critical to the development of the SARS-CoV2 mRNA vaccines. With over 300 laboratories carrying out RNA research, Canada is recognized internationally for the quality and innovation of its RNA research.
RNA Canada ARN’s mission is to develop a comprehensive strategy to discover, leverage and apply RNA-based discoveries with high impact and of tremendous benefits to Canadians. The Canadian RNA ecosystem is dynamic, interactive, and ideally suited to embark on a concerted effort to maximize the outcome of innovative RNA technology. The creation of RNA Canada ARN reflects the enthusiasm and the leadership of Canadian RNA research scientists in harnessing the power of RNA for the benefit of all Canadians.
